Come up with a name for your new list and we'll add to it:
Aliva Biopharmaceuticals raised a round of funding on January 14, 2008. Investors include
National Science Foundation.
Aliva Biopharmaceuticals is a company that received a SBIR Phase I grant for a project entitled: Humanized Mouse Ig system employing BAC. Their research project aims to introduce the entire human immu…